1. Home
  2. ASMB vs PED Comparison

ASMB vs PED Comparison

Compare ASMB & PED Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ASMB
  • PED
  • Stock Information
  • Founded
  • ASMB 2005
  • PED N/A
  • Country
  • ASMB United States
  • PED United States
  • Employees
  • ASMB N/A
  • PED N/A
  • Industry
  • ASMB Biotechnology: Pharmaceutical Preparations
  • PED Oil & Gas Production
  • Sector
  • ASMB Health Care
  • PED Energy
  • Exchange
  • ASMB Nasdaq
  • PED Nasdaq
  • Market Cap
  • ASMB 92.1M
  • PED 77.0M
  • IPO Year
  • ASMB 2010
  • PED N/A
  • Fundamental
  • Price
  • ASMB $14.82
  • PED $0.87
  • Analyst Decision
  • ASMB Buy
  • PED Strong Buy
  • Analyst Count
  • ASMB 2
  • PED 3
  • Target Price
  • ASMB $35.00
  • PED $1.83
  • AVG Volume (30 Days)
  • ASMB 32.6K
  • PED 165.0K
  • Earning Date
  • ASMB 11-07-2024
  • PED 03-17-2025
  • Dividend Yield
  • ASMB N/A
  • PED N/A
  • EPS Growth
  • ASMB N/A
  • PED 125.69
  • EPS
  • ASMB N/A
  • PED 0.02
  • Revenue
  • ASMB $28,326,000.00
  • PED $35,719,000.00
  • Revenue This Year
  • ASMB $282.16
  • PED $26.32
  • Revenue Next Year
  • ASMB N/A
  • PED $2.77
  • P/E Ratio
  • ASMB N/A
  • PED $34.54
  • Revenue Growth
  • ASMB N/A
  • PED 19.19
  • 52 Week Low
  • ASMB $9.84
  • PED $0.61
  • 52 Week High
  • ASMB $19.93
  • PED $1.10
  • Technical
  • Relative Strength Index (RSI)
  • ASMB 42.21
  • PED 52.68
  • Support Level
  • ASMB $14.15
  • PED $0.81
  • Resistance Level
  • ASMB $14.95
  • PED $1.00
  • Average True Range (ATR)
  • ASMB 0.87
  • PED 0.05
  • MACD
  • ASMB -0.12
  • PED 0.00
  • Stochastic Oscillator
  • ASMB 8.97
  • PED 31.93

About ASMB Assembly Biosciences Inc.

Assembly Biosciences Inc is a clinical-stage biotechnology company. It is advancing two innovative platform programs, a novel class of oral therapeutics for the treatment of hepatitis B virus (HBV) infection and novel class of oral synthetic live biotherapeutics, which are designed to restore health to a dysbiotic microbiome. The company's HBV-cure program is aimed at increasing the current low cure rate for patients with HBV and is pursuing multiple drug candidates that inhibit multiple steps of the HBV lifecycle. Assembly has discovered several novel core protein Allosteric Modulators, which are small molecules that directly target and allosterically modulate the HBV core protein. The majority of the revenue is generated from the HBV cure program.

About PED Pedevco Corp.

PEDEVCO Corp is an oil and gas company focused on the acquisition and development of oil and natural gas assets in modern drilling and completion techniques and technologies have yet to be applied. The company focuses on legacy proved properties where there is a long production history, well-defined geology and existing infrastructure that can be leveraged when applying modern field management technologies. The current properties of the company are located in the San Andres formation of the Permian Basin situated in West Texas and eastern New Mexico (the Permian Basin) and in the Denver-Julesberg Basin (D-J Basin) in Colorado and Wyoming.

Share on Social Networks: